false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
Apophysomyces Elegans Mucormycosis in a Young Immu ...
Apophysomyces Elegans Mucormycosis in a Young Immunocompetent Patient
Back to course
Pdf Summary
This case report describes a 41-year-old immunocompetent man from Arizona who developed severe orbital and facial mucormycosis caused by <strong>Apophysomyces elegans</strong> after extensive yard work. He presented with 3 days of right orbital swelling, fever, chills, tinnitus, and decreased sensation in the right V2 distribution. Initial workup showed preseptal cellulitis on CT, but subsequent surgery and pathology confirmed invasive fungal disease with necrotic tissue, non-septate hyphae, angioinvasion, and osteomyelitis of the orbital and skull structures. Cultures grew <strong>A. elegans</strong> along with additional organisms. The infection required aggressive management, including ethmoidectomy, right orbitotomy with enucleation, skull lesion resection/reconstruction, and repair of a CSF leak. He was treated with <strong>liposomal amphotericin B</strong> and <strong>posaconazole</strong>, plus meropenem for bacterial co-infection. Despite treatment, he developed complications including acute kidney injury from amphotericin B and contrast exposure, punctate brain infarcts likely from fungal spread, and recurrent infection requiring rehospitalization and repeat surgery. The presentation emphasizes that <strong>mucormycosis can occur in patients without classic risk factors</strong>. Although diabetes, hematologic malignancy, transplant, and corticosteroid exposure are common predisposing conditions, a significant minority of cases occur in otherwise healthy patients. <strong>Apophysomyces elegans</strong> is notable for infecting immunocompetent hosts, especially in endemic regions such as the southern United States, including Arizona. Key lessons include maintaining a high index of suspicion for mucormycosis in patients with relevant environmental exposure, pursuing early diagnosis, and initiating prompt surgical and antifungal treatment to improve outcomes. The report also notes the broader global rise in mucormycosis during the COVID-19 era, potentially linked to increased corticosteroid use.
Asset Subtitle
Joseph W. Budenske
Meta Tag
Author List
Evan Brickner, Joao Paulo Albuquerque Ferreira, Joseph W. Budenske, Rajesh Kotagiri, Tirdad Zangeneh
Category
Clinical Vignettes
Concept
Mucormycosis
Concept
Immunocompromised State
Concept
Apophysomyces elegans
Concept
Orbital Swelling
Concept
Facial Swelling
Distinguished
Non-Finalist
Presenter Organization
University of Arizona College of Medicine Tucson
Presenting Author
Joseph W. Budenske
Track
Adult
Keywords
mucormycosis
Apophysomyces elegans
orbital infection
immunocompetent host
Arizona
liposomal amphotericin B
posaconazole
angioinvasion
osteomyelitis
surgical debridement
Mucormycosis
Immunocompromised State
Apophysomyces elegans
Orbital Swelling
Facial Swelling
×
Please select your language
1
English